SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-23-000125
Filing Date
2023-08-11
Accepted
2023-08-11 16:04:51
Documents
1
Period of Report
2023-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691784273.html 4  
1 FORM 4 wk-form4_1691784273.xml 4 7750
  Complete submission text file 0001439222-23-000125.txt   9205
Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 231163968

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences